Shukra Pharmaceuticals Limited (BOM:524632)
India · Delayed Price · Currency is INR 42.24
-2.22 (-4.99%)
At close: Feb 12, 2026
Shukra Pharmaceuticals Market Cap
Shukra Pharmaceuticals has a market cap or net worth of 18.5 billion as of February 13, 2026. Its market cap has increased by 88.07% in one year.
Market Cap
18.50B
Enterprise Value
18.40B
Revenue
645.69M
Ranking
n/a
PE Ratio
106.52
Stock Price
42.24
Market Cap Chart
Since February 23, 2012, Shukra Pharmaceuticals's market cap has increased from 46.16M to 18.50B, an increase of 39,968.36%. That is a compound annual growth rate of 53.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 18.50B | -28.71% |
| Dec 31, 2025 | 25.94B | 334.48% |
| Dec 31, 2024 | 5.97B | 340.79% |
| Dec 29, 2023 | 1.35B | 554.74% |
| Dec 30, 2022 | 206.90M | 58.55% |
| Dec 30, 2021 | 130.50M | 105.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 31.33B |
| Unichem Laboratories | 27.17B |
| Hikal | 22.74B |
| Bliss GVS Pharma | 21.94B |
| Morepen Laboratories | 21.93B |
| Novartis India | 20.72B |
| Amrutanjan Health Care | 18.43B |
| Syncom Formulations (India) | 13.48B |